Back
Cyclerion Therapeutics Vs. Harvard Bioscience Industry Stock Comparison
Buy
52
CYCN
Cyclerion Therapeutics
Last Price:
$3.24
Seasonality Move:
-0.35%
Sell
40
HBIO
Harvard Bioscience
Last Price:
$2.11
Seasonality Move:
6.15%
Buy
52
Cyclerion Therapeutics (CYCN)
is a Buy
Is Cyclerion Therapeutics a Buy, Sell or Hold?
-
The current Cyclerion Therapeutics [CYCN] share price is $3.19. The Score for CYCN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CYCN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Harvard Bioscience (HBIO)
is a Sell
Is Harvard Bioscience a Buy, Sell or Hold?
-
The current Harvard Bioscience [HBIO] share price is $2.11. The Score for HBIO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
HBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYCN Stock Price Chart
What is Cyclerion Therapeutics's stock price today?
-
The Cyclerion Therapeutics share price today is $3.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYCN is experiencing slight buying pressure.
HBIO Stock Price Chart
What is Harvard Bioscience's stock price today?
-
The Harvard Bioscience share price today is $2.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HBIO is experiencing slight buying pressure.
CYCN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 50.98 | Buy |
Chaikin Money Flow: | 51000 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.67 - 4.13) | Buy |
Bollinger Bands (100): | (2.13 - 3.49) | Buy |
HBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 42.86 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.11 - 2.27) | Sell |
Bollinger Bands (100): | (2.24 - 2.86) | Sell |
CYCN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.31 | Sell |
20-day SMA: | 3.13 | Buy |
50-day SMA: | 2.76 | Buy |
200-day SMA: | 2.87 | Buy |
8-day EMA: | 3.26 | Sell |
20-day EMA: | 3.17 | Buy |
50-day EMA: | 2.91 | Buy |
200-day EMA: | 3.06 | Buy |
HBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.16 | Sell |
20-day SMA: | 2.21 | Sell |
50-day SMA: | 2.3 | Sell |
200-day SMA: | 3.05 | Sell |
8-day EMA: | 2.14 | Sell |
20-day EMA: | 2.2 | Sell |
50-day EMA: | 2.32 | Sell |
200-day EMA: | 2.97 | Sell |
Cyclerion Therapeutics Earnings Growth & CYCN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Harvard Bioscience Earnings Growth & HBIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.08 per share.
Cyclerion Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Harvard Bioscience Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |